Delisting riskPopularity #4,321
ZSTK · NASDAQ · Asset Management

ZeroStack (ZSTK)

Stakes 0G tokens and distributes pharmaceuticals through its German Phatebo business.

$3.95
After hours−0.16 (−3.89%)
At close$4.11(−4.86%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue1718181612131215109714
Cost of revenue121414131011912912815
Gross profit534333330−3−1−1
5116779454211
Research & development000000000000
564558453211
Selling & marketing111112111000
General & administrative353446342200
Other expenses152111001000
Operating income−1−7−2−4−4−6−1−3−3−4−1−2
10−1100000−106−35−22
Interest income000000000000
Interest expense000000000000
Other non-operating income−101000000000
Income before tax1−8−3−3−4−6−1−2−4−110−37−24
Income tax expense000000000000
Net income from continuing operations1−7−3−3−4−6−1−2−4−110−37−25
Discontinued operations0−2000000−3000
Net income1−10−3−3−4−6−1−2−7−110−37−25
EPS, basic$0.09−$36.16−$14.76−$8.35−$11.03−$16.88−$1.54−$4.27−$9.05−$105.07−$3.68−$2.47
EPS, diluted$0.08−$36.16−$14.76−$8.35−$11.03−$16.88−$1.54−$4.27−$9.05−$105.07−$3.68−$2.47
Weighted average shares, basic70000001111010
Weighted average shares, diluted80000001111010
EBITDA1−7−3−3−4−60−2−3−1−2
Depreciation & amortization00000000000
EBIT1−7−3−3−4−6−1−2−4−4−1−2